James Abell

Mr. James Abell is a high-net-worth investor based at London, United Kingdom. He is a Partner and Chief Financial Officer at Abingworth. He joined Abingworth in 1998 where he handles finance and administration as well as investment matters, focusing on start-up companies. His directorships have included Avillion, Chroma Therapeutics, Clinical Designs and Syntaxin. He manages his own investments.